mass) were significantly greater (P < 0.05) for liver, heart, kidneys and plantaris muscle in fetuses derived from co-cultured embryos, and for liver in fetuses derived from SOF+ embryos than those for control fetuses. Fetuses derived from co-cultured embryos were 34% heavier (P < 0.001) and fetuses derived from SOF+ embryos were 18% heavier (P < 0.01) by day 125 of gestation than those derived from control embryos. Growth coefficients for liver and heart for fetuses derived from co-culture and SOF+ embryos were also significantly greater (P < 0.05) at this stage of gestation than those for control group fetuses. In contrast, allometric coefficients for these organs in fetuses derived from embryos cultured in SOF without serum supplementation were not different from those for controls. Excessive volumes of amniotic fluid (polyhydramnios) were observed in 23% of conceptuses derived from co-cultured embryos. In vitro embryo culture can significantly influence fetal growth and this study provides quantitative evidence of major shifts in the patterns of organ and tissue development.
Introduction
Advanced reproductive technologies can deliver substantial benefits to livestock production through their ability to increase the rate of genetic gain within genetic improvement programmes and to enhance the rate of dissemination of improved genetic material (Woolliams and Wilmut, 1989; Brash et ah, 1996; Sinclair and Broadbent, 1996) . New industries are being generated on the basis of the production of transgenic animals with the ability, for example, to produce novel proteins for use in human medicine (Wilmut and Whitelaw, 1994 ). An integral part of these new technologies is in vitro embryo culture. However, reports of unusually large offspring in ruminants after the transfer to recipients of embryos cloned by nuclear transfer or cultured in vitro, with associated complications at birth resulting in high perinatal morbidity and mortality (for review, see Walker et ah, 1996;  Kruip and den Daas, 1997; Young et ah, 1998) , are impeding the adoption of such technologies in these species.
Field-scale trials with cattle have provided quantitative information on the effects on birth weight of nuclear transfer (Willadsen et ah, 1991; Wilson et ah, 1995) and in vitro more subtle but fundamental shifts in organ and tissue development than have been reported. These developmental shifts may occur at a much higher frequency and could, in addition to influencing neonatal morbidity and mortality, impinge on postnatal growth and longevity. Therefore, the purpose of this study was to describe any such changes in the growth and development of sheep fetuses derived from in vitro cultured embryos.
Materials and Methods
The experiment described in this paper was reviewed by the Animals and Welfare Committees of the Scottish Agricultural College and was conducted under the auspices of, and in accordance with the requirements of, the Home Office Animals (Scientific Procedures) Act, 1986. Animals and experimental design Mature Scottish Blackface ewes, with no overt disease or reproductive abnormalities, were assembled in August 1995 and assigned randomly to be either zygote donors, embryo donors or recipients. The donor ewes were superovulated and artificially inseminated using semen from the single Suffolk sire used by Sinclair et ah (1998) . Zygotes recovered from these donors were cultured in vitro for 5 days on one of three treatments: (a) a granulosa cell co-culture system (coculture); (b) unsupplemented synthetic oviductal fluid medium (SOF-); or (c) synthetic oviductal fluid medium supplemented with serum (SOF+). Control embryos were recovered from superovulated donor ewes at day 6 after oestrus (day 0). All embryos were transferred singly at day 6 to synchronous recipients. Gravid uteri were recovered at day 61 and day 125 of gestation.
Embryo production and transfer
Oestrous cycles were synchronized in both donor and recipient ewes using progestogen-releasing intravaginal sponges (30 mg fluorogestone acetate, Chronogest, Intervet, Cambridge) for 12 days. For recipient ewes, the same sponge remained in position for 12 days whereas, for donor ewes, it was removed and a second sponge was inserted after 7 days. Recipients received 400 iu pregnant mares' serum gonadotrophin (Intervet, Cambridge) Organ (liver, heart and kidneys) and muscle (plantaris and tibialis anterior) masses were significantly greater (P < 0.01) in fetuses derived from the co-culture treatment than in fetuses derived from the control treatment at day 61 of gestation (Table 3) . Kidneys were also significantly heavier in fetuses derived from the SOF+ treatment than in controls (1.20 g versus. 0.98 g; < 0.05), but the tibialis anterior muscle was significantly lighter in SOF4-fetuses than in fetuses derived from the control treatment (36.6 mg versus 44.7 mg; < 0.05).
Allometric coefficients, relating component mass to fetal mass, were significantly greater (P < 0.05) for liver, heart, kidneys and plantaris muscle in fetuses derived from the co-culture treatment than for those components derived from control treatment; and were greater for liver in fetuses derived from SOF4-than for liver derived from the control treatment (Table 4 ; Fig. 1 indicated that organ masses of oversized fetuses were greater than predicted and that organ development had been fundamentally altered. At day 125 of gestation, both the gravid uterus and chorioallantois were significantly heavier for the co-culture and SOF+ treatments than they were for the control and SOF-treatments (P < 0.05; Table 6 ). Mean conceptus fluid mass was significantly greater (P < 0.01) for the co-culture treatment than for the other treatments. The mass of fluid for three conceptuses (3/13 or 23%) from this treatment was > 3 SD above the mean of the control treatment. The mass of fluid for five conceptuses (5/13 or 38%) from the same treatment was greater than that for the heaviest conceptus from the control treatment. Fetuses derived from the co-culture treatment were, on average, 1121 g or 34% heavier (P < 0.001), and 47 mm or 9% longer (P < 0.001) than fetuses from the control treatment. Fetuses derived from the SOF+ treatment were 585 g heavier (18%; < 0.05), and were associated with a larger chorioallantois (P < 0.05) and total gravid uterus mass (P < 0.05) than fetuses derived from the control treatment.
There was a weak but significant (r = 0.55; < 0.01) correlation between cotyledon mass and the mass of fetuses derived from embryos cultured in each of the three in vitro systems.
All organ and muscle masses, and humérus lengths at day 125 of gestation were greater (P < 0.001) for fetuses derived from the co-culture treatment than those from the control treatment (Table 7) . Both (1998) for fetuses derived from in vivo produced embryos (Table 8 ). This analysis allowed treatment effects on organ size to be compared in the absence of confounding effects of Fig (Robinson, 1981) .
Allometric coefficients established for each of the visceral organs and muscle tissues recovered from fetuses derived from co-cultured embryos indicate that their development was altered. Large fetuses from this treatment group had disproportionately large visceral organs and muscles. Histological examination of the fetal plantaris muscle at days 61 and 125 of gestation in the present study (Maxfield et ah, 1998) showed that the increased muscle development arising from co-culturing embryos with granulosa cells was due to an increase in primary muscle fibre hypertrophy and an increase in secondary muscle fibre hyperplasia and hyper¬ trophy, resulting in increases in the secondary:primary muscle fibre ratio and muscle mass.
A similar picture is apparent for fetuses derived from embryos that were cultured in synthetic oviductal fluid with added serum. Although the effect of this treatment was allometric equations (y = organ mass; = fetal mass) were liver, log^i/ = -2.17 + 0.857 log.x; heart, logry = -^1.30 + 0.922 logex; Vo-culture allometric equations (y = organ mass; = fetal mass) were liver, log^y = -4.10 + 1.379 logfx; heart, y = -7.76 + 1.70 log,*; "control: masses of fetuses derived from in vivo produced embryos in present experiment. Means with different superscripts within rows are significantly different (P < 0.05).
Includes amnion.
For description of treatments, see Table 1 . SOF-: synthetic oviductal fluid medium without serum; SOF+: synthetic oviductal fluid medium supplemented with human serum; CRL: curved crown-rump length. (Walker et ah, 1992b) and cerebellar dysplasia (Schmidt et ah, 1996 (Watson et ah, 1992 (Watson et ah, ,1994 (Leighton et ah, 1996) and because similar phenotypes to those observed in the present study exist in both humans and mice when expression of such genes has been altered (Young et ah, 1998 (Farin and Farin, 1997; Young et ah, 1998) . However, the coculture and SOF+ systems in the present study provide robust, repeatable and relatively efficient models for the study of the fetal oversize syndrome.
